
The Irregular Border
There is increasing interest in so-called alternative medicine. Both patients and practitioners are clearly interested in this domain and this is in striking contrast to the bright, shining edifice of evidence-based medicine.
We are at an exciting time in medicine. A nearly exponential increase in the understanding of biology, chemistry, and pharmacology figuratively strains the digital shelves that hold all of this knowledge, while giant leaps in information technology mean that it is all accessible with a few taps of a smartphone. Modern medicine has more answers than ever before, and a new era of evidence-based decision-making has taken hold, bringing light and clarity to dark, unknown realms.
And yet, all is not well in this exciting new world of data and reason: there is unrest. There is increasing interest in so-called alternative medicine, which can be defined in a number of ways, but perhaps most pointedly as medicine that is simply not evidence-based. Both patients and practitioners are clearly interested in this domain and this is in striking contrast to the bright, shining edifice of evidence-based medicine. Indeed, studies indicate some 50% of dermatology patients - our patients - have tried one or more forms of alternative medicine.
If modern medicine is so great - and it clearly is - why are people seeking these alternatives? Three major motivations seem to lie at the root of this movement:
- diseases that are not curable;
- explanations that are unsatisfying; and
- treatments that are thought to be unsafe and/or only symptomatic.
Another reason may have to do with the experience of seeing a doctor in the modern day: rushed, harried, and often more focused on the computer than on the patient. This is probably not how our forebears envisioned the art of medicine being practiced. In Dermatology - perhaps particularly so - these are all strongly represented: Many of our diseases are chronic and incurable; much of our understanding of the pathophysiology is incomplete; thus, many of our explanations fall short; and we have many treatments that only offer a temporary reprieve from a condition and yet still have many potential side effects.
Sadly, it does not seem likely that these conditions will be going away anytime soon for the majority of dermatologic diseases, which brings us to this column. Each month we hope to explore different diseases and treatments, looking into alternative approaches and their rationale. We will focus on the evidence: It may be surprising how much evidence is actually available in some areas. And, as we delve deeply, the line between alterative and mainstream may become a bit blurrier than it seemed at first blush. Above all else, we hope that it is stimulating and useful, for both skeptic and believer.
Atopic dermatitis (AD)
As we all know too well, this chronic, relapsing, itchy condition often begins in the first years of life, but may affect patients of all ages. Its etiopathogenesis is complex and still not fully understood, but the most recent research points to a combination of skin barrier dysfunction, immunologic aberrations, microflora imbalance, and abnormalities in the perception of itch.
The conventional approach to treatment for AD includes addressing the four main areas of dysfunction with moisturization, anti-inflammatory agents, anti-microbials, and anti-pruritic therapy. Allergen identification and avoidance of triggers is also helpful when possible.
More recently, however, there has been increased scrutiny of topical corticosteroids: highly effective though they may be, but with a significant number of concerning side effects that make them undesirable for certain patients. This perception may lead to poor adherence to the plan, with more than one third of patients admitting to nonadherence to treatment in the setting of topical corticosteroid phobia in one study.
This makes for very fertile ground for alternative medicine, with many possible theories and approaches. We will limit ourselves to a few that have some decent evidence for potentially being useful, and also look at two that seem likely to be unhelpful, although they are frequently discussed.
Sunflower seed oil
The skin barrier is of critical importance in AD, and is likely the primary issue in at least some types of eczema. Sunflower (Helianthus annus) seed oil is rich in linoleic acid, a fatty acid that can help maintain the skin barrier and decrease transepidermal water loss, both of which could be helpful for the barrier dysfunction in AD.
When put to the test, the evidence points to at least a modest effect in AD. A study of 86 children with moderate AD randomized to corticosteroids with or without a sunflower-oil-containing cream found a significant impact on lichenification and excoriation, decreased corticosteroid use, and improved quality of life compared to the control group.
Another study of 19 adults randomized to receive olive oil to one arm versus sunflower seed oil to the other found that the olive oil actually caused a worsening of the barrier function and erythema. Sunflower seed oil, on the other hand, preserved skin barrier function and improved hydration.
Coconut oil
Bacterial infection (usually with staphylococcus) is a major issue in AD. Coconut oil (Cocos nucifera) has been shown to address another closely-related issue in atopic dermatitis: staphylococcal colonization. In a randomized controlled trial it was found to clear an impressive 95% of staphylococcal colonization in patients with AD.
Topical vitamin B12
Beyond topical corticosteroids and calcineurin inhibitors (which appear to do much of their work via anti-inflammatory pathways), there is not much in the armamentarium to combat the itch of AD. Antihistamines are often unhelpful, and a variety of over-the-counter cooling preparations offer only limited relief. Vitamin B12 (cobalamin) is a powerful scavenger of nitric oxide-which has been linked to triggering pruritus-making it a compelling consideration for treating AD. Additionally, in vitro studies have demonstrated that B12 suppresses the cytokine production of T lymphocytes and multiple inflammatory cytokines, also promising for AD therapy.
When put to the test, a double-blinded randomized control trial of topical B12 in children with AD found significant improvement in the active group over the placebo at 2 and 4 weeks.
Acupuncture, acupressure
Generally considered a part of Traditional Chinese Medicine, acupuncture and acupressure build upon the idea that energy meridians in the body can become unbalanced and that by stimulating certain points (“acupoints”) with needles, pressure, magnets, or even lasers, the flow can be restored and rebalanced.
From a conventional standpoint, there are studies that show clear changes in specific brain areas with acupuncture, and evidence that there is endorphin production with acupuncture, suggesting a neurocutaneous connection.
The study that got me excited about acupuncture was actually not in atopic dermatitis at all, but rather for the intractable itch of uremic pruritus. 40 patients with severe, refractory pruritus related to kidney failure were randomized to acupuncture at one point (Large Intestine 11, located near the antecubital fossa) three times weekly or acupuncture at a sham point for 1 month. At 1 month and 3 months, the itch was significantly lower in the actual acupuncture group (p<0.001), suggesting a real effect.
Inspired by that study, we carried out a pilot study of acupressure-a tiny titanium bead that was massaged on that same acupuncture spot by the patient instead of a needle inserted by an acupuncturist-in 15 adults with moderate-severe AD.
Evening primrose oil and borage oil
Finally, we have discussed many promising ideas, and perhaps it’s also important to close the door on some not-so-promising ones. Evening primrose oil and borage oil both have a somewhat mixed set of evidence from trials. The rationale being that these natural oils are rich in gamma-linolenic acid, which may benefit the skin barrier and may have anti-inflammatory and anti-itch properties.
“Oral borage oil and evening primrose oil lack effect on eczema; improvement was similar to respective placebos used in trials… [W]e concluded that further studies on EPO or BO for eczema would be hard to justify.”
This is a powerful statement, to be sure, but in some ways a welcome one. With so many possibilities and relatively limited resources to test them all, crossing something off the list is actually good news and allows us to focus on things that may yet hold promise but require more research.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


















